were infected with a recombinant MHV-A59, also expressing gp33-41, as a fusion protein with enhanced green fluorescent protein
(EGFP). By 5 days postinfection, these mice showed significantly (approximately 20-fold) lower titers of
infectious virus in the brain compared to control mice